Clinical Gastroenterology and Hepatology

Scope & Guideline

Elevating Standards in Gastroenterology and Hepatology

Introduction

Explore the comprehensive scope of Clinical Gastroenterology and Hepatology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Clinical Gastroenterology and Hepatology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1542-3565
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2003 to 2024
AbbreviationCLIN GASTROENTEROL H / Clin. Gastroenterol. Hepatol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The journal 'Clinical Gastroenterology and Hepatology' is dedicated to advancing the field of gastroenterology and hepatology through the publication of high-quality research. Its scope encompasses a wide range of topics related to digestive health, liver diseases, and the application of innovative diagnostic and therapeutic strategies.
  1. Gastrointestinal Diseases and Disorders:
    The journal focuses on various gastrointestinal diseases, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastrointestinal cancers, providing insights into their pathophysiology, diagnosis, and management.
  2. Liver Disease Research:
    A significant emphasis is placed on liver diseases, particularly those related to nonalcoholic fatty liver disease (NAFLD), hepatitis B and C, liver cirrhosis, and hepatocellular carcinoma, exploring novel treatment options and surveillance strategies.
  3. Endoscopic Techniques and Innovations:
    The journal highlights advancements in endoscopic procedures, including innovations in techniques like endoscopic submucosal dissection, peroral endoscopic myotomy, and the use of artificial intelligence in endoscopy.
  4. Patient-Centered Care and Quality Improvement:
    Research on patient outcomes, quality of care, and health disparities in gastrointestinal and liver diseases is a core focus, emphasizing the importance of patient-centered approaches and health equity.
  5. Dietary and Lifestyle Interventions:
    The journal also addresses the role of dietary therapies and lifestyle modifications in managing gastrointestinal and liver conditions, including the impact of diet on disease progression and symptom relief.
The journal has recognized several emerging themes that reflect current trends and advancements in the field of gastroenterology and hepatology. These topics are gaining traction and are likely to shape future research and clinical practice.
  1. Artificial Intelligence in Gastroenterology:
    There is a growing focus on the application of artificial intelligence (AI) in gastrointestinal diagnostics and treatment, particularly in enhancing endoscopic procedures and improving accuracy in disease detection.
  2. Integrated Care Models:
    Emerging research emphasizes integrated care models that combine gastroenterology with other specialties, addressing the multifaceted nature of gastrointestinal and liver diseases, particularly in patients with comorbidities.
  3. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
    MAFLD is increasingly recognized as a significant health concern, leading to a surge in studies investigating its epidemiology, risk factors, and treatment options, reflecting a paradigm shift from the traditional NAFLD nomenclature.
  4. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated the adoption of telemedicine in gastroenterology, with ongoing research into its efficacy and patient satisfaction, indicating a potential long-term change in how care is delivered.
  5. Patient-Centered Outcomes and Quality of Life:
    Research is increasingly focusing on patient-reported outcomes and quality of life measures, acknowledging the importance of these factors in the management of chronic gastrointestinal and liver diseases.

Declining or Waning

While 'Clinical Gastroenterology and Hepatology' continues to thrive in many areas, certain themes have seen a decline in prominence over recent years. This may reflect shifting research priorities and emerging understanding within the field.
  1. Traditional Pharmacological Treatments:
    There is a noticeable decline in studies focusing solely on traditional pharmacological treatments, as the field shifts towards personalized medicine and biologic therapies that offer more targeted approaches to treatment.
  2. Generalized Screening Practices:
    Research on generalized screening practices for conditions like colorectal cancer has waned, with a shift towards risk-based and personalized screening strategies that consider individual patient factors.
  3. Non-Invasive Testing for Liver Disease:
    The frequency of studies centered around older non-invasive testing methods for liver disease has decreased, as newer, more accurate technologies and biomarkers are being developed and validated.

Similar Journals

Journal of Gastrointestinal and Liver Diseases

Championing Comprehensive Understanding in Gastroenterology
Publisher: MEDICAL UNIV PRESSISSN: 1841-8724Frequency: 4 issues/year

The Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.

With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.

International Journal of Hepatology

Bridging research and clinical practice in hepatology.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Leading the way in pediatric gastroenterology and nutrition advancements.
Publisher: WILEYISSN: 0277-2116Frequency: 12 issues/year

Journal of Pediatric Gastroenterology and Nutrition is a premier academic journal published by Wiley, focusing on the critical intersection of pediatric gastroenterology and nutrition. Established in 1982, this journal has been at the forefront of research and clinical practices for over four decades and continues to contribute invaluable insights to the fields of pediatrics and gastrointestinal health, boasting a Q1 ranking in Pediatrics, Perinatology and Child Health and a Q2 ranking in Gastroenterology as of 2023. The journal features a comprehensive array of original research, review articles, and clinical studies aimed at improving the understanding and management of pediatric gastrointestinal disorders and nutrient imbalances. Edited with expertise, the Journal of Pediatric Gastroenterology and Nutrition serves as an essential resource for clinicians, researchers, and students dedicated to advancing the well-being of children with digestive health issues. Readers can access the journal's impactful research studies through traditional subscriptions.

Translational Gastroenterology and Hepatology

Bridging Discovery and Care in Gastroenterology.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

DIGESTIVE AND LIVER DISEASE

Innovating research for better patient outcomes.
Publisher: ELSEVIER SCIENCE INCISSN: 1590-8658Frequency: 12 issues/year

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

Minerva Gastroenterology

Exploring New Frontiers in Digestive Health Research
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-5985Frequency: 4 issues/year

Minerva Gastroenterology, published by EDIZIONI MINERVA MEDICA, is a notable academic journal dedicated to advancing the field of gastroenterology and related disciplines. With an ISSN of 2724-5985 and an E-ISSN of 2724-5365, this journal gathers innovative research from diverse areas including internal medicine, endocrinology, and metabolism. Though characterized by its open-access policies, Minerva Gastroenterology aims to provide a platform for high-quality scholarly articles with an emphasis on critical reviews, clinical studies, and translational research. Since its inception in 2021, the journal has managed to secure a reputation reflected in its Q3 rank across multiple categories in 2023, as well as its standing in Scopus rankings, positioning it in the 45th to 47th percentile among renowned medical journals. Situated in Turin, Italy, it fosters collaboration and knowledge-sharing among researchers and practitioners, making it an essential resource for those seeking to deepen their understanding of gastroenterological conditions and enhance clinical practices.

Cellular and Molecular Gastroenterology and Hepatology

Transforming the landscape of gastroenterology and hepatology.
Publisher: ELSEVIER INCISSN: 2352-345XFrequency: 12 issues/year

Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.

Clinical and Molecular Hepatology

Advancing liver health through innovative research.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

Korean Journal of Gastroenterology

Championing Breakthroughs in Gastroenterology
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Uncovering the latest in digestive health advancements.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.